![]() The Library's collections include around 14 million books, along with substantial holdings of manuscripts and items dating as far back as 2000 BC. The British Library is a major research library, with items in many languages and in many formats, both print and digital: books, manuscripts, journals, newspapers, magazines, sound and music recordings, videos, play-scripts, patents, databases, maps, stamps, prints, drawings. The Library is a non-departmental public body sponsored by the Department for Digital, Culture, Media and Sport. As a legal deposit library, the British Library receives copies of all books produced in the United Kingdom and Ireland, including a significant proportion of overseas titles distributed in the UK. ![]() It is estimated to contain between 170 and 200 million items from many countries. The British Library is the national library of the United Kingdom and is one of the largest libraries in the world. Roly Keating (chief executive, since 12 September 2012) Open to anyone with a need to use the collections and services Copyright and Related Rights Act, 2000 (Republic of Ireland).Legal Deposit Libraries Act 2003 (United Kingdom).With this book as their guide, students and pharmaceutical researchers can learn how to use drug repositioning techniques to extend the lifespan and applications of existing drugs as well as maximize the return on investment in drug research and development.British Library building at St Pancras from the piazzaġ July 1973 (49 years ago) ( 1 July 1973)ĥ1☃1′46″N 0☀7′37″W / 51.52944°N 0.12694°W / 51.52944 -0.12694 Coordinates: 51☃1′46″N 0☀7′37″W / 51.52944°N 0.12694°W / 51.52944 -0.12694īooks, journals, newspapers, magazines, sound and music recordings, patents, databases, maps, stamps, prints, drawings and manuscripts The book's appendix provides valuable resources for drug repositioning researchers, including information on drug repositioning and reformulation companies, databases, government resources and organizations, regulatory agencies, and drug repositioning initiatives from academia and non-profits. ![]() ![]() Part 3, Academic and Non-Profit Initiatives & the Role of Alliances in the Drug Repositioning Industry, explores current investigations for repositioning drugs to treat rare and neglected diseases, which are frequently overlooked by for-profit pharmaceutical companies due to their lack of commercial return. Part 2, Application of Technology Platforms to Uncover New Indications and Repurpose Existing Drugs, sets forth computational-based strategies, tools, and databases that have been designed for repositioning studies, screening approaches, including combinations of existing drugs, and a look at the development of chemically modified analogs of approved agents. Part 1, Drug Repositioning: Business Case, Strategies, and Operational Considerations, examines the medical and commercial drivers underpinning the quest to reposition existing drugs, guiding readers through the key strategic, technical, operational, and regulatory decisions needed for successful drug repositioning programs. Readers will learn how to perform the latest experimental and computational methods that support drug repositioning, and detailed case studies throughout the book demonstrate how these methods fit within the context of a comprehensive drug repositioning strategy.ĭrug Repositioning is divided into three parts: This book examines the business, technical, scientific, and operational challenges and opportunities that drug repositioning offers. The how's and why's of successful drug repositioningĭrug repositioning, also known as drug reprofiling or repurposing, has become an increasingly important part of the drug development process.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |